A. Abbas

发表

Numerical modeling of failed rifts in the northern South China Sea margin: Implications for continental rifting and breakup

S. Zlotnik, Chun‐Feng Li, T. Sun, 2020 .

Subcutaneous Epcoritamab in Combination with Rituximab + Lenalidomide (R2) for First-Line Treatment of Follicular Lymphoma: Initial Results from Phase 1/2 Trial

P. Abrisqueta, F. Awan, K. Drott, 2022, Blood.

Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update

S. de Vos, P. Abrisqueta, H. Holte, 2022, Blood.

Subcutaneous epcoritamab with rituximab + lenalidomide (R2) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): Update from phase 1/2 trial.

S. de Vos, H. Holte, S. Leppä, 2022, Journal of Clinical Oncology.

Mantle serpentinization beneath a failed rift and post-spreading magmatism in the northeastern South China Sea margin

X. Qiu, Jiazheng Zhang, Chun‐Feng Li, 2021 .

Epcoritamab (epco) with gemcitabine + oxaliplatin (GemOx) in patients (pts) with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) ineligible for autologous stem cell transplant (ASCT) induces high response rate even in pts failing CAR T therapy.

T. Phillips, P. Lugtenburg, J. Brody, 2022, Journal of Clinical Oncology.

First-line treatment (Tx) with subcutaneous (SC) epcoritamab (epco) + R-CHOP in patients (pts) with high-risk diffuse large B-cell lymphoma (DLBCL): Phase 1/2 data update.

J. Brody, F. Offner, S. Snauwaert, 2022, Journal of Clinical Oncology.

EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

S. de Vos, P. Abrisqueta, H. Holte, 2023, Hematological Oncology.

Epcoritamab + R2 regimen and responses in high-risk follicular lymphoma, regardless of POD24 status.

S. de Vos, P. Abrisqueta, H. Holte, 2023, Journal of Clinical Oncology.

Risk Comparison of Karachi Stock Exchange with Next Eleven Countries: A Country Beta Approach

M. Abrar, Dr. Muhammad Zia ur Rehman, S. Baig, 2014 .